|

PF-08634404 Clinical Trials

10 actively recruiting trials across 8 locations

No change since July 2026

Also known as: SSGJ-707

Pipeline

Phase 2: 2Phase 3: 2Phase 1/2: 4Phase 2/3: 2

Top Sponsors

  • Pfizer10

Indications

  • Cancer10
  • Lung Cancer5
  • Non Small Cell Lung Cancer3
  • Carcinoma, Non-Small-Cell Lung (NSCLC)2
  • Small Cell Lung Cancer (SCLC)2

Fayetteville, Arkansas3 trials

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Highlands Oncology Group, PA

Phase 1/2
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Highlands Oncology Group

Phase 2/3
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Highlands Oncology Group, PA

Phase 1/2

Huntsville, Alabama1 trial

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Clearview Cancer Institute (Crestwood)

Phase 2

Bullhead City, Arizona1 trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Pioneer Research Center

Phase 3

Chandler, Arizona1 trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Ironwood Cancer & Research Centers

Phase 3

Phoenix, Arizona1 trial

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Mayo Clinic Building- Phoenix

Phase 1/2

Duarte, California1 trial

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

City of Hope National Medical Center

Phase 2

Los Angeles, California1 trial

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Keck Hospital of USC

Phase 1/2

Aurora, Colorado1 trial

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Rocky Mountain Cancer Centers, LLP

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.